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Abstract
A causative agent of human malaria, Plasmodium falciparum, is transmitted by Anopheles mosquitoes. The malaria parasite is
under intensive attack from the mosquito’s innate immune system during its sporogonic development. We have used
genetic engineering to create immune-enhanced Anopheles stephensi mosquitoes through blood meal-inducible expression
of a transgene encoding the IMD pathway-controlled NF-kB Rel2 transcription factor in the midgut and fat-body tissue.
Transgenic mosquitoes showed greater resistance to Plasmodium and microbial infection as a result of timely concerted
tissue-specific immune attacks involving multiple effectors. The relatively weak impact of this genetic modification on
mosquito fitness under laboratory conditions encourages further investigation of this approach for malaria control.
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Introduction
One of the world’s deadliest diseases, malaria, is caused by
protozoan parasites of the genus Plasmodium, which are transmitted
by Anopheles mosquitoes. The absence of effective vaccines and the
development of drug-resistant parasites and insecticide-resistant
mosquitoes have accentuated the need for novel strategies for
malaria control.
The transmission of malaria parasites between human hosts
relies on the successful completion of its complex lifecycle in the
mosquito vector. The innate immune system of Anopheles, this
malaria vector’s main line of defense against the Plasmodium
parasite, is engaged at multiple stages of parasite infection [1–3].
Among the most potent anti-Plasmodium immune factors identified
to date are TEP1, APL1, LRRD7, and FBN9, all controlled by the
IMD pathway through its transcription factor Rel2 [4–12].
Through alternative splicing, the Rel2 gene produces a full-length
form (Rel2-F), which includes the carboxyl-terminal ankyrin
(ANK) and death domains, and a shorter form (Rel2-S) lacking
these inhibition domains, which is constitutively translocated to
nucleus, where it actives the transcription of several anti-microbial
peptide (AMP) and anti-Plasmodium effector genes [9].
We and others have shown that RNAi-based depletion of the
negative regulator of Rel2, Caspar, results in near complete
refractoriness of the three major malaria vectors, A. gambiae, A.
stephensi, and A. albimanus, to the human parasite P. falciparum, and
that over-expression of Rel2 in transgenic Aedes aegypti mosquitoes
results in increased resistance to the avian malaria parasite P.
gallinaceum [13]. Interestingly, transient activation of Rel2 through
gene silencing of Caspar is associated with a minimal fitness cost in
mosquitoes, in terms of their longevity and fecundity under
laboratory conditions [4]. These properties of the IMD pathway
and its downstream transcription factor Rel2 suggest that, if
appropriately manipulated, they could be used for the develop-
ment of malaria control strategies based on Plasmodium falciparum-
resistant genetically modified mosquitoes.
Although the innate immune system of mosquitoes has been
intensively studied and a plethora of anti-Plasmodium effector genes
have been discovered over the past two decades, the application of
this knowledge to the development of novel malaria control
strategies has not been thoroughly investigated. In this study, we
have for the first time explored this approach through the
development of genetically modified immune-enhanced Anopheles
mosquitoes that express the active form of the Rel2( Rel2-S)
transcription factor under the control of the blood meal-inducible
carboxylpeptidase (Cp) or vitellogenin (Vg) promoter [14,15], in
order to target the malaria parasite at its early stages of
development (i.e., those associated with the lumen and basal side
of the mosquito’s midgut tissue). We generated Cp-Rel2 and Vg-
Rel2 transgenic lines, as well as a third hybrid immune-enhanced
transgenic line with blood meal-inducible expression of Rel2i n
both the midgut and fat-body tissue compartments. These three
transgenic mosquito lines displayed potent anti-P. falciparum
activity and provide a unique opportunity to elucidate the spatial
and temporal specificities of the mosquito’s Rel2-mediated anti-
Plasmodium defenses. Longevity and fecundity studies of these
immune-enhanced transgenic mosquito lines, under laboratory
conditions, suggested only a weakly negative impact of transgene
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we show for the first time that the mosquito’s innate immune
system can be used in a genetic engineering approach to develop a
control strategy for human malaria.
Results/Discussion
Generation and characterization of Cp-Rel2 and Vg-Rel2
transgenic mosquitoes
We generated transgenic Anopheles mosquito lines that over-
expressed an active form of Rel2( Rel2S) under the control of the
blood meal-inducible midgut- or fat-body- specific promoters.
Given the ease of germ line transformation in the A. stephensi
malaria vector, which also uses the conserved IMD pathway to
control infection with P. falciparum [4], we chose this species for our
analyses. The A. gambiae Rel2S was PCR-amplified (primers given
in Table S1) and separately ligated to the A. gambiae carboxypep-
tidase A (AgCp) and vitellogenin 1 (AgVg) promoters in independent
constructs, and the terminator sequence of the A. gambiae trypsin
gene (TryT) was ligated downstream of Rel2S (Figure S1A). These
two cassettes, AgCp-Rel2-TryT and AgCp-Rel2-TryT, were sepa-
rately cloned into the piggyBac-based plasmids pBac[3xP3-
EGFPafm] and pBac[3xP3-DsRedafm] [16] containing the eye-
specific 3xP3 promoter-driven GFP or DsRed as selection markers
for the screening of transgenic mosquitoes (Figure S1A).
By embryo microinjection of these plasmids together with the
helper plasmid, we generated 11 Cp-Rel2 and 3 Vg-Rel2 A. stephensi
transgenic mosquito lines with stable GFP (Cp lines) and DsRed
(Vg lines) eye fluorescence (Figures 1A and S1B). Transgenic
mosquitoes were outcrossed with non-transgenic colony A. stephensi
(referred to as wild-type [wt] controls) for the first four generations
to maintain the heterozygous lines. In order to identify the
transgenic lines with the most potent anti-Plasmodium activity, the
fourth and fifth generations of the heterozygous eleven Cp- and
three Vg- transgenic mosquito lines were fed on a P. falciparum
gametocyte culture and the infection intensity was compared to
that of wt control colony mosquitoes. This analysis showed that in
two consecutive generations of heterozygous mosquitoes, the Cp11
and Vg1 lines displayed the least susceptibility to P. falciparum
infection, as indicated by oocyst numbers on the midgut’s basal
side (p,0.0001, pooled from two biological replicates from 2
consecutive generations) (Figure S2A-B). Both PCR and Southern
hybridization of the genomic DNA from the fourth generation of
the transgenic larvae of Cp11 and Vg1 confirmed the transgene
insertion (Figure S1C-D). Southern hybridization analysis showed
that the genomes of most transgenic lines harbored only one copy
of the transgene, while Cp2, Cp6, and Vg2 had two copies (Figure
S1D). The exact chromosome locations of the transgene could not
be determined because of the lack of an assembled A. stephensi
genome sequence. The heterozygous transgenic lines except Cp1
displayed different degrees of resistance to P. falciparum infection
(Figure S2), suggesting that the positional effect of the transgene
activity should be taken into consideration when implementing a
transgenic mosquito approach for malaria control, given the fact
that variations in transgene location and copy number result in
different expression of the transgene (effector molecule). The copy
number of the transgene did not correlate with the degree of
resistance to P. falciparum infection (Figures S1 and S2), suggesting
that one copy of the Rel2 transgene is sufficient to activate the
downstream anti-Plasmodium effector genes, and that a positional
effect on transgene activity plays a more important role in
determining resistance. A positional effect could for example
influence expression of the transgene Rel2, other IMD pathway
factors and the downstream effector genes, and thereby result in
different degrees of anti-Plasmodium activity. One transgene could
also influence the expression and activity of another transgene
when inserted into the same genome, and the abundance of the
transcription factor that activates the transgene will influence its
overall transcription. A genetic engineering approach which relies
on random integration of the transgene in the genome is therefore
useful to determine an optimal integration site for transgene
function. A genetic drive system with site-specific recombination,
that ensures transgene integration into a defined genomic location,
can then be implemented to optimize this system for a malaria
control strategy [17–20].
After five generations of outcrossing, the heterozygous Cp11
and Vg1 were subsequently interbred to generate homozygous
Cp11 and Vg1 lines for further characterization (see details in
Materials and Methods section). By crossing homozygous Cp11
female mosquitoes with Vg1 male mosquitoes, we generated a
third hybrid transgenic immune-enhanced mosquito line with
blood meal-inducible expression of Rel2 in both the midgut and
fat-body tissue compartments; these three independent lines,
homozygous Cp11, Vg1, and the heterozygous hybrid (hereafter
referred to as Cp, Vg, and Hyb, respectively), were used
throughout this study for the infection assays (Figures 1A and
S1B).
The transgene AgRel2 activates IMD pathway-regulated
effector genes in A. stephensi
To determine whether the AgRel2 transgene can activate the
expression of downstream AMP and anti-P. falciparum effector
genes in the A. stephensi transgenic mosquitoes, we identified
orthologs of the A. gambiae immune genes Gambicin, Defensin, TEP1,
LRRD7, PGRP-LC, APL1A, and APL1C [8,10,11,21–23] in the A.
stephensi genome contig sequence database, then used these
sequences for qRT-PCR expression analyses (primer sequences
are listed in Table S2). BLAST analyses with A. stephensi genome
contig sequences suggested that this species only harbors one APL1
gene in its genome [5,7]. A recent study showed that the APL1
genes are exceptionally polymorphic and under co-evolution with
TEP1 [12]. Therefore we designed one pair of primers for the A.
stephensi APL1 gene, and semi-quantitative RT-PCR of the genes at
Author Summary
Malaria is caused by the Plasmodium parasites which are
transmitted by the Anopheles mosquitoes, and the
mosquito’s innate immune system plays an important role
in blocking the parasite at several sporogonic stages. Our
previous studies have shown that one of the major
mosquito immune pathways, IMD, is important in the
defense against the human malaria parasite in three major
malaria vectors, Anopheles gambiae, A. stephensi, and A.
albimanus. The transcription factor Rel2 is regulated by the
IMD pathway and controls the expression of several potent
anti-Plasmodium immune factors. In this study, we have
used germ-line transformation technology to generate
transgenic Anopheles stephensi mosquitoes with blood
meal-inducible expression of Rel2 transcripts in both
midgut and fat-body tissues. These transgenic mosquitoes
were close to completely resistant to human malaria
parasites as a result of the timely concerted tissue-specific
expression of anti-Plasmodium effector genes. Under
laboratory conditions, the fitness cost of this genetic
modification was minimal, suggesting that this system
could be utilized for the development of a malaria control
strategy.
Transgenic Mosquito Immunity to Plasmodium
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induced (data not shown). Through qRT-PCR we show that blood
meal-inducible over-expression of Rel2 (Figure 1B) in the
transgenic mosquito midgut and fat-body results in significantly
increased transcript abundance of several IMD pathway-regulated
anti-microbial and anti-Plasmodium genes (Gambicin, Defensin, TEP1,
LRRD7, PGRP-LC) [10,11,21,22,24] in a temporal and spatial
pattern that suggested effective targeting of the malaria parasite.
The abundance of the midgut-specific carboxypeptidase-driven
Rel2 (Cp) transcript peaked at about 6–12 h after blood ingestion,
when the parasite is confined to the blood meal in the midgut
lumen (Figure 1B) [14,25]; in contrast, the transcript abundance of
the fat-body- specific vitellogenin-driven Rel2 (Vg) peaked at about
12–24 h after blood ingestion [13,15,26], when the parasite is
reaching the basal side of the midgut tissue and it can be more
readily targeted by defense mechanisms from the fat-body
compartment. However, although Rel2 is highly induced in
response to a blood meal, its peak expression subsides rapidly
after 24 h, suggesting that the induction of an IMD pathway
immune response is transient and may not have a strong impact on
the transgenic mosquitoes’ fitness.
Impact of Rel2 over-expression on Plasmodium infection
at different sporogonic stages
To assess the anti-Plasmodium activity of the three transgenic
immune-enhanced mosquito lines, we fed these lines (homozygous
Cp11 and Vg1, heterozygous Hyb), along with wt control
mosquitoes, on either NF54 or 3D7 (GFP) P. falciparum gametocyte
cultures or on a P. berghei (GFP)-infected Swiss Webster mouse. All
three transgenic immune-enhanced mosquito lines were signifi-
cantly less susceptible to the highly virulent P. falciparum strain
NF54 at the pre-oocyst stage (Figure 1C-G and Table S3). The
homozygous Cp and Vg mosquito lines displayed a similar degree
of Plasmodium resistance compared to the heterozygous mosquitoes
(Figures 1D and S2). When the mosquitoes were fed on a
laboratory P. falciparum gametocyte culture (0.3%) that is known to
result in unnaturally high infection intensities and prevalence, the
proportion of mosquitoes with at least one oocyst (infection
prevalence) decreased significantly in the Cp and Hyb mosquitoes
compared to the wt controls (Figure 1D and Table S3; Chi-square
test: Cp, p=0.003; Hyb, p=0.0001). The oocyst infection intensity
in all three lines was significantly reduced (by 77.1%, 48.6%, and
82.9% in the Cp11, Vg1, and hybrid transgenic mosquitoes,
Figure 1. Resistance of genetically engineered Rel2-expressing immune-enhanced A. stephensi to P. falciparum. (A) Fluorescent images
of larvae and adults of the vitellogenin- (Vg, red) and carboxypeptidase- (Cp, green) driven Rel2 transgenic lines and hybrid (Hyb, merged into yellow)
transgenic line, along with the wt control (WT, non-fluorescent) strain. (B) qRT-PCR analysis of -fold changes in the expression of the Rel2 transgene
and effector genes at 0 to 48 h post-blood-meal (PBM), with standard errors shown. Dots represent fold change in expression of the genes of interest
(GOI) of the transgenic mosquito tissues compared to that of wt mosquito tissues at the corresponding time PBM. The ribosomal protein S7 gene was
used for normalization of the cDNA templates. (C) Green fluorescent P. falciparum (3D7(GFP)) oocysts in the midguts of WT control, Cp (Cp11), Vg
(Vg1), and Hyb mosquitoes at 8 days post-infection (dpi). (D, E) P. falciparum (NF54) oocyst loads (including zeros) of WT control, homozygous Cp11
and Vg1 and heterozygotes hybrid transgenic mosquitoes at 8 dpi when fed on blood with a standard 0.3% (D) and 0.05% (E) gametocytemia. (F) P.
falciparum (NF54) ookinete loads in the midgut lumen at 24 h post-infection (hpi). (G) P. falciparum (NF54) sporozoite loads in the salivary glands at
14 dpi. Assays were performed with at least three biological replicates, and the numbers of parasites from equal numbers of samples (midguts,
midgut lumen, or salivary glands) from different replicates were pooled for the dot-plot. Each dot represents the number of oocysts, ookinetes, or
sporozoites in an individual midgut, midgut lumen, or salivary gland respectively, and the horizontal lines (red) indicate the median values. Mann-
Whitney test determined p-values (shown here) and Kruskal-Wallis test was used to calculate p-values and determine the significance of oocysts,
ookinetes, or sporozoites numbers. Detailed statistical information of infection assays with N, range, prevalence, p-values of prevalence determined
by Chi-square test, median (with or without zeros), p-values of infection intensity (with or without zeros) calculated through Kruskal-Wallis and Mann-
Whitney tests, and % decrease of oocysts, ookinetes, or sporozoites loads are presented in Table S3.
doi:10.1371/journal.ppat.1002458.g001
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Table S3; p,0.001). The hybrid and midgut-specific (Cp-Rel2)
transgenic lines were more resistant to Plasmodium infection than
was the fat-body-specific (Vg-Rel2) line, suggesting that the parasite
is more susceptible to immune attack by carboxypeptidase-driven
Rel2-mediated activation of the IMD pathway in the midgut, when
anti-Plasmodium effector genes are expressed at least 6 h earlier
than those expressed by the fat-body-driven transgene Rel2. We
confirmed this hypothesis by showing that the two lines (Cp, Hyb)
expressing recombinant Rel2 in the midgut tissue were able to
decrease the number of ookinete stage parasites prior to invasion
of the midgut epithelium (Figure 1F and Table S3), whereas the
fat-body-specific Rel2 line (Vg-Rel2) only displayed an increased
capacity to inhibit the post-invasion stages of Plasmodium
(Figure 1C–E and Table S3). However, since the immune
induction of several effector genes was lower in the Vg line
compared to the Cp line, we cannot rule out that a more potent
driver (promoter) in the fat body (i.e. a different fat-body
promoter) might result in an equivalent or stronger protection
again Plasmodium parasites. These immune defenses resulted in a
profound decrease in the infectious sporozoite-stage parasites in
the mosquito salivary gland (Figure 1G). The degree of inhibition
that we observed was similar to that previously found in other
studies utilizing transgenic mosquitoes, but mainly non-human
malaria parasites [14,27–29].
The P. falciparum laboratory strain used in this study was selected
for its ability to produce unnaturally high infection levels averaging
as much as 100 oocysts per mosquito in some assays of our study,
as compared to a parasite load under natural field conditions that
rarely exceeds 2–3 oocysts per mosquito [30]. We therefore
hypothesized that the transgenic immune-enhanced mosquito
strains would most likely display a greater level of resistance under
such natural transmission conditions. To test this hypothesis, we
artificially suppressed infections by feeding mosquitoes on P.
falciparum infected blood at a 6-fold lower gametocytemia (0.05%)
than usual (0.3% gametocytemia). This approach produced a
refractory state in the immune-enhanced mosquitoes, with a
median oocyst count of zero (mean of 0.64) (Figure 1E and Table
S3); in contrast, non-transgenic wt control mosquitoes had a
median oocyst count of 3 and mean of 3.56. Furthermore, the
infection prevalence was 28% in the hybrid line which is
significantly lower than the 80% in the wt control mosquitoes
(Chi-square test, p,0.0001) (Figure 1E and Table S3). However,
when mosquitoes with zero oocysts were excluded from the
analysis, no differences in the oocyst infection intensities were
detected between the three different transgenic lines, corroborat-
ing the importance of prevalence when studying Plasmodium
infection of the mosquito midgut (Table S3). Considering the
somewhat unnaturally high levels of infection (exceeding 5 oocysts
in 28% of the wt mosquitoes) in this assay, one can expect an even
higher proportion of completely resistant transgenic mosquitoes
under field conditions, which are characterized by a lower
infection rate and prevalence [31]. The level of refractoriness of
our immune-enhanced transgenic mosquitoes to the human
malaria parasite is similar to that described by Corby-Harris
et al., with an unknown mechanistic basis; in that case, the mean
oocyst number per mosquito was 0.18, as compared to 3.89 for the
wt mosquitoes [32].
Mosquitoes frequently feed multiple times on blood within the
,12-day time window prior to the sporozoites’ invasion of the
salivary glands; this repeated feeding would expose the later
sporogonic stages of Plasmodium to enhanced immune responses in
the immune-enhanced transgenic mosquitoes. When we provided
a second naı ¨ve blood meal 8 days after the parasite-infected blood
meal, we saw a non-significant trend (2-fold, Mann-Whitney test,
p=0.089) of decreased sporozoite loads in the salivary glands
when compared to mosquitoes receiving only one infectious blood
meal, suggesting that the transgene Rel2-mediated immune
response may not implicated in controlling the parasites at the
later sporogonic stages (Figure S3). However, the time point of
transgene induction upon the second blood meal might not have
been optimal for anti-Plasmodium defense at this stage, and
therefore warrants further analysis.
Transgenic expression of Rel2 resulted in a lesser degree of
resistance to the rodent malaria parasite P. berghei, in only the Cp-
and hybrid transgenic lines (Figure S4 and Table S3; Mann-
Whitney test: Cp, p=0.0209; Hyb, p=0.0142). Kruskal-Wallis test
suggests that overall transgenic mosquitoes showed marginally
elevated resistance to rodent malaria parasites (p=0.0363) (Table
S3). This result is in agreement with earlier studies showing that
the IMD pathway has a more pronounced effect on the human
malaria parasite [4,33].
The Rel2 transgene confers resistance to P. falciparum
through multiple effector genes
To provide further insight into the mechanism underlying the
immune-enhanced mosquitoes’ resistance to P. falciparum, we show
that silencing of the Rel2-regulated anti-Plasmodium factors, TEP1,
APL1, and LRRD7 results in a greater susceptibility to P.
falciparum infection in transgenic mosquitoes [4,5,8,23]. To
confirm the efficiency of gene silencing, qRT-PCR was used to
validate transcript depletion prior to feeding on infected blood and
at 24 h post blood meal (Table S2). Our data show that each of
these anti-Plasmodium factors was, at least partially, responsible for
the transgene Rel2-mediated resistance since their silencing did not
result in an increased infection level to the same degree as did their
silencing in wt mosquitoes (Figure 2). This observation, taken
together with the blood meal-inducible transcription of these genes
(Figure 1B), suggests that Rel2-dependent immune activation
generates an anti-Plasmodium response through a combination of
effector molecules that can each attack the parasite independently
or synergistically. Our earlier studies have shown that some of
these genes engage in independent Plasmodium killing mechanisms,
while others may act together [4]. PGRP-LC gene silencing in the
wt mosquitoes resulted in a trend of, but statistically insignificant,
increased susceptibility to the Plasmodium infection, probably due to
a lower silencing efficiency (Table S2) and/or the midgut
microflora –elicited basal level of immune activation [33]. The
complete lack of effect of PGRP-LC gene silencing on the
resistance to Plasmodium infection in the transgenic mosquitoes
may suggest that the modulation of anti-Plasmodium effector genes
through the Rel2 transgene supersedes the modulation of the
endogenous IMD pathway by PGRP-LC (Figure 2). The midgut-
and fat-body- specific Rel2 transgenic mosquitoes generated in this
study offer a unique platform for the spatial and temporal
dissection of this anti-Plasmodium mechanism at molecular and
cellular levels.
Transgene Rel2-mediated anti-bacterial defenses
In nature, mosquitoes are exposed to a variety of microbes, both
via injury and from their normal intestinal flora, and the IMD
pathway was originally identified as the insect’s main defense
against Gram-negative bacteria [34,35]. The immune-enhanced
transgenic mosquitoes that express Rel2 in their midgut tissue
displayed elevated resistance to the microbes of their midgut flora,
which mainly consist of Gram-negative species (Figure 3A),
corroborating findings from previous studies[36,37]. At 24 to
72 h post-blood meal (PBM), the bacterial loads in the Cp11 and
Transgenic Mosquito Immunity to Plasmodium
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suggesting that Cp promoter-driven over-expression of Rel2 in the
midgut mediated a robust expression of AMPs, which were acting
against the midgut bacteria even when bacterial loads peaked at
48 h PBM (Student’s t-test, p,0.01). Only the LB culturable
microbial flora was assessed which was composed of the dominant
bacteria Serratia spp. and Cryseobacterium spp. from laboratory-
reared female mosquito midguts [36,37].
Compared to those expressing Rel2 only in the midgut,
mosquitoes that expressed Rel2 in both the midgut and fat-body
tissue displayed significantly greater resistance to systemic
challenge (thoracic microbial injection) with the Gram-negative
bacterium E. coli (Kaplan-Meier survival analysis, p,0.05), as well
as with the Gram-positive bacterium S. aureus (Kaplan-Meier
survival analysis, p,0.05) (Figures 3B and S5) (detailed Kaplan-
Meier survival curves are presented in Figure S5 with three
biological replicates shown). Interestingly, increased survival can
also be observed in PBS-injected transgenic mosquitoes when
compared to the wt parental mosquitoes which might be
contributed from the introduction of bacteria through the injection
process. The fitness trade-offs between a potentially costly
bloodmeal-inducible immune response and the predicted favor-
able effect of an increased resistance to certain bacteria will be
interesting to address in greater detail in future studies. However,
one could also argue that a reduction of the microflora through
recombinant Rel2 expression could counteract the anti-Plasmodium
activity of certain natural midgut bacteria [38], and further studies
will be necessary to examine this possibility.
Figure 2. Implication of anti-Plasmodium effector genes in refractoriness of immune-enhanced transgenic mosquitoes. Depletion of
TEP1, APL1, LRRD7, and PGRP-LC through RNAi-mediated gene silencing resulted in changes in the P. falciparum oocyst intensity at 8 dpi in the non-
transgenic wild type (WT), Cp, Vg, and hybrid transgenic mosquitoes. GFP dsRNA-injected mosquitoes served as control. Points indicate the absolute
value of oocyst counts in individual mosquitoes, and horizontal red bars in each column represent the median value of oocysts from three replicates.
P-values were calculated by Mann-Whitney test. (*: p,0.05; **: p,0.01; ***: p,0.001; ****: p,0.0001). Detailed statistical information of infection
assays with n, range, prevalence, median, p-values, and % increased oocysts load are presented in the table beneath the figure as well as in Table S3.
doi:10.1371/journal.ppat.1002458.g002
Figure 3. Antibacterial resistance of immune-enhanced transgenic mosquitoes. (A) The midgut microbial flora (total bacterial load) of
female transgenic and wt control (WT) mosquitoes at 24, 48, and 72 h PBM (mean6SEM). A Student’s t-test was used to calculate p-values and
determine significance. (B) Survival rates of transgenic mosquitoes upon challenge with either Gram-negative (E. coli: 350,000 CFU) or Gram-positive
(S. aureus: 210,000 CFU) bacteria at 4 dpi. Kaplan-Meier survival analysis with log-rank test was used to determine the p-values, and p,0.05 indicates
significance (detailed Kaplan-Meier survival curves with three biological replicas are presented in Figure S5). (C) P. falciparum oocyst infection
intensities in the septic (non-antibiotic treated) and aseptic (antibiotic-treated) transgenic and WT mosquitoes at 8 dpi. Antibiotic-treated wt
mosquitoes became more susceptible to P. falciparum infection than did non-antibiotic-treated wt mosquitoes, while oocyst intensities in transgenic
hybrid mosquitoes showed no change. At least three biological replicates are included, with each dot representing the number of oocysts in an
individual midgut, and the horizontal lines (red) indicating the median values. P-values were calculated by a Mann-Whitney test.
doi:10.1371/journal.ppat.1002458.g003
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microbioal flora is responsible for a basal activation of the IMD
pathway-regulated immune genes, which in turn influence
resistance to Plasmodium [24,37]. To determine whether the
presence or absence of midgut bacteria would influence the
resistance of transgenic immune-enhanced mosquitoes to Plasmo-
dium infection, we performed identical infection assays with wt and
hybrid transgenic mosquitoes under septic (non-antibiotic treated)
and antibiotic-treated aseptic conditions. While removal of the
majority of the midgut bacterial flora (either LB culturable or
Giemsa stainable) through antibiotic treatment resulted in an
increased susceptibility to Plasmodium infection in the wt control
mosquitoes, as shown earlier, the resistance of the transgenic
immune-enhanced line was not affected (Figure 3C), suggesting
that the recombinant Rel2 prevails over the activity of the bacteria-
inducible endogenous Rel2. The dominance of the Rel2 transgene
upon blood meal induction was also indicated by our experiments
in which depletion of PGRP-LC, which acts upstream of the IMD
pathway, had no effect on resistance to Plasmodium infection
(Figure 2).
Rel2 immune-enhanced transgenic mosquitoes display a mar-
ginal decrease in longevity and fecundity under laboratory rearing
conditions. Immune responses are generally known to be
associated with fitness trade-offs [39-41], and these associations
could compromise the implementation of a immune-enhanced
transgenic mosquito for malaria control. When mosquitoes were
maintained on a 10% sugar solution in the absence of a blood
meal that would induce the expression of the Rel2 transgene, the
longevity of the immune-enhanced mosquito strains did not differ
from that of the parental wt control strain under laboratory
rearing conditions (Figure 4A and Table S4) (detailed statistical
analysis for three biological replicates are listed in Table S4).
Exposure of immune-enhanced transgenic mosquitoes to a single
naı ¨ve blood meal resulted in an increased longevity of one and two
cohorts of Cp and hybrid mosquitoes, respectively (Figure 4B and
Table S4). There was an insignificant change in the survival of the
transgenic mosquitoes after multiple naı ¨ve blood meals, with only
one cohort of Cp transgenic mosquitoes possessing a longer life
span (Figure 4C and Table S4). After a single Pf-infected blood
meal, hybrid mosquitoes showed a significant reduction in
longevity in three independent assays (Kaplan-Meier survival
analysis, p,0.05), while one cohort of Cp and Vg mosquitoes also
displayed a significantly shorter life span (Figure 4D and Table
S4). Fecundity, as a measure of egg-laying capacity, was only
slightly lower in the transgenic fat-body Rel2-expressing strain
(Figure 4E), possibly because of a decreased expression of the egg
yolk protein vitellogenin during IMD pathway activation
(Figure 4F), as also shown by an earlier study [42], and a likely
competition between the transgenic and endogenous Vg promot-
ers. Furthermore, the egg hatch rate was unaffected by the
transgene in the case of all three immune-enhanced mosquito
strains (Figure 4G).
Our data are consistent with earlier studies in D. melanogaster
which showed that a transient activation of the IMD pathway,
through overexpression of a PGRP gene (PGRP-LE), did not
influence fly fitness as a measure of longevity under abundant and
limited food provision and the ability of the flies to jump [43].
These studies also showed that a constitutive activation of this
pathway did result in a significant decrease on longevity. However,
the fitness impact of transgene effector molecule expression needs
to be addressed in a greater detail prior to the implementation of a
malaria control strategy. The fitness parameters addressed in this
study are limited and do therefore not fully predict the overall
fitness of the immune-enhanced transgenic mosquitoes. Other
parameters, such as fertility, larval biomass productivity, develop-
mental rate, adult emergence, male ratio, and mating competi-
tiveness including life table analysis and cage experiments, as
suggested in [44–46], will be addressed in future studies.
Nevertheless, our fitness assays suggest that the fitness loss
associated with expression of the transgene Rel2 is unlikely to
impair the spread of the immune-enhancement trait in natural
mosquito populations when an effective genetic drive system that
can overcome fitness disadvantages is employed [17,18]. For
example, the Drosophila Medea elements are predicted to convert an
entire population into element-bearing heterozygotes and homo-
zygotes even at a 15% element-associated fitness cost, when these
elements are introduced into the population at relatively high
frequencies [17].
In conclusion, we have genetically engineered A. stephensi
mosquitoes to spatially and temporally express the Rel2 transgene
in both midgut and fat-body tissues after a blood meal; thereby
activating robust expression of several AMPs and anti-Plasmodium
effector genes. We have investigated the spatial and temporal
impact of Rel2-mediated innate immune responses on P. falciparum
development and found that over-expression of several anti-
Plasmodium effector genes (TEP1, APL1, LRRD7) in these Rel2
transgenic mosquitoes contributed to the Plasmodium-refractory
phenotype. Over-expression of Rel2 in both the midgut and fat-
body tissue in these mosquitoes limited the proliferation of the
midgut microbial flora, and increased the mosquitoes’ resistance to
systemic challenge with Gram-negative bacteria. By using single
and hybrid transgenic lines, we also addressed for the first time the
fitness implications of the mosquito’s Rel2-mediated innate
immune responses in various tissues in a transgenic context and
demonstrated that transient activation of Rel2 in the gut tissue has
only a minimal impact on relevant fitness parameters under
laboratory conditions, and this finding is consistent with an earlier
study using Drosophila [43]. At this stage we cannot exclude the
possibility of some parasites developing resistance to this blocking
mechanism, and the fact that some of our transgenic mosquitoes
possessed sporozoites in their salivary glands corroborates the need
for further studies of this defense system. A different spatial-
temporal transgene induction profile or the combination of
multiple anti-Plasmodium transgenes may render mosquitoes
completely parasite-proof.
Our current and previous studies have shown that a transgenic
Rel2-mediated innate immune response fulfills several criteria
required for an anti-Plasmodium effector system that could be used
for malaria control. First, we have shown that genetically modified
immune-enhanced mosquitoes activate multiple anti-Plasmodium
factors that are likely to act independently or synergistically against
Plasmodium, thereby decreasing the possibility for the development
of resistance by the parasite [4–6,8,9,23]. It is, however, important
to note that it remains to be demonstrated that this approach will
provide protection in the field, with its enormous genetic diversity
of wild Plasmodium populations. Second, Rel2 confers resistance to
P. falciparum in three independent and evolutionary divergent
malaria vector species, as well as to the bird malaria species P.
gallinaceum in Aedes aegypti, potentially rendering this approach
feasible for application to the ,40 different Anopheline vectors of
malaria [4,13]. Third, the fitness effect of transient Rel2 activation
in the midgut tissue, as measured by longevity and fecundity under
laboratory conditions, would not impair the spread of the
transgene by a powerful genetic drive system [17,18]. Fourth,
our approach did not involve the introduction of a foreign
recombinant gene, but only an enhancement of the mosquito’s
innate immune system through over-expression of its own Rel2
transcription factor through its own carboxypeptidae and
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unexpected adverse effects relating to expression of a heterologous
protein. A plausible future scenario could involve the spread of a
Rel2 transgene through a powerful genetic drive system that can
overcome the fitness cost of transgene expression, thereby
conferring enhanced-immune properties on existing natural
malaria vector populations. This approach has the advantage of
being logistically simple and self-propagating as well as environ-
mentally friendly, since it does not eliminate the mosquito from its
ecologic niche or involve chemical insecticide or drug treatments.
In sum, we have for the first time shown, as a proof of principle,
that the mosquito’s innate immune system has the potential to be
used in a genetic engineering approach to block the transmission
of human malaria parasites.
Materials and Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Animal Care and Use Committee of
the Johns Hopkins University (Permit Number: M006H300).
Commercial anonymous human blood was used for parasite
cultures and mosquito feeding and informed consent was therefore
not applicable. The Johns Hopkins School of Public Health Ethics
Committee has approved this protocol.
Mosquito rearing and antibiotic treatments
A. stephensi Liston strain mosquitoes were maintained under
laboratory conditions at 27uC and 80% humidity with a 12 h day-
night cycle. Larvae were reared on cat food pellets and ground fish
food supplement. Adult mosquitoes were maintained on 10%
sucrose and fed on mouse blood (mice were anesthetized with
ketamine) for egg production. The antibiotic treatment of the
mosquitoes was performed according to [37] to obtain mosquitoes
with an eliminated LB culturable midgut microbial flora. In brief,
a single cohort of adult female mosquitoes was collected
immediately after eclosion and placed in a sterile environment.
In the first consecutive 4-day period after eclosion, adult female
mosquitoes were reared on a fresh filter-sterilized 10% sucrose
solution containing 15 mg gentamicin sulfate (Sigma) and
10 units/10 mg of penicillin-streptomycin (Invitrogen) per ml.
The efficacy of removal of the majority of bacteria in the gut of
Figure 4. Fitness assessment of immune-enhanced transgenic mosquitoes. (A–D) Life spans of transgenic and wt mosquitoes maintained
on 10% sucrose solution (A); or mosquitoes fed on a single naı ¨ve human blood 5 d post emergence and then maintained on sugar solution (B); or
mosquitoes that were provided 3 naı ¨ve blood meals (days 0, 4, 8) and then maintained on sugar solution (C); or mosquitoes that were provided a Pf-
infected blood meal (0.3% gametocytemia) and then maintained on sugar solution (D). The mean values from three replicates are shown, with the
standard error bars. Survival rates were analyzed by Kaplan-Meier survival analysis with Wilcoxon test to determine the significance, and detailed
statistical information is shown in Table S4. (E) Eggs laid by female transgenic and wt mosquitoes from three biological replicates: Each dot
represents the eggs laid by an individual female after a single blood meal. The median values (red horizontal bars) are shown. P-values were
calculated with a Mann-Whitney test. (F) -Fold change in the expression of the A. stephensi endogenous vitellogenin 1 (AsVg1) gene, at 6, 12, 24, and
48 h PBM (mean6SEM) compared to that of the non-fed mosquitoes. The cDNA templates were normalized using the AsS7 gene. (G) Hatch rates
indicate the average percentage of eggs giving rise to 1st instar larvae, as determined by three biological replicates. Mean values for hatch rates and
standard errors (SE) of replicates are indicated.
doi:10.1371/journal.ppat.1002458.g004
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homogenate on LB-agar plates and through Giemsa staining of
midgut homogenates as described in [37]. One day prior to
feeding on P. falciparum-infected blood, mosquitoes were provided
with fresh filter-sterilized sugar without antibiotics. Antibiotic
treatment was applied again after feeding until dissection.
Transformation vector constructs
For the mosquito germ-line transformation, we used the
pBac[3xP3-EGFPafm] and pBac[3xP3-DsRedafm] transforma-
tion vectors containing an eye-specific promoter (3xP3) in front of
the TATA box, as described in [16]. The active form (1840 bp) of
the A. gambiae Rel2( Rel2S) lacking the ankyrin repeats and death
domains [9] was first cloned into the pBluescript vector at the
EcoRI site (Stratagene). The Rel2 primers used for amplifying the
PCR product from A. gambiae cDNA were: 59-GCAGTGGT-
CAGTGTTGGAGAG-39 (forward primer) and 59-TTCCGAGT-
TACAGGGGAA GTC-39 (reverse primer). A 392-bp DNA
fragment of the putative terminator region of trypsin was obtained
by PCR from the vector pENTR-carboxypeptidase P-antryp1T
(kindly provided by Dr. Yoshida) [28] and was cloned downstream
of Rel2 at the SpeI/NotI site of the pBluescript vector. The A.
gambiae vitellogenin 1 promoter (1800 bp) was obtained from A.
gambiae gDNA, and the carboxypeptidase A promoter (2311 bp)
was obtained by PCR from the vector pENTR-carboxypeptidase
P-antryp1T [28] (primer sequences listed in Table S1). Both
promoters were separately cloned in-frame upstream of the Rel2
into the pBluescript vector. The AgVg-Rel2S-TryT and AgCp-Rel2S-
TryT cassettes were individually digested and cleaved from the
FseI site in the pBluescript vector, then cloned into the FseI sites of
the pBac[3xP3-DsRedafm] or the pBac[3xP3-EGFPafm] vector,
respectively. These two resulting plasmids, pBac-DsRed[AgVg-
Rel2-TryT] and pBac-EGFP[AgCp-Rel2-TryT], were then used for
injection into the A. stephensi embryos (Figure S1).
Generation of transgenic mosquitoes
For the germ-line transformation, the donor (Rel2-containing
plasmids) and helper plasmid phsp-pBac were prepared using the
Qiagen Endofree Maxi Prep kit and re-suspended in 1x
microinjection buffer according to published methods [14,47–
48]. A mixture of 0.25 mg/ml of the Rel2 plasmid and 0.25 mg/mlo f
the helper plasmid DNA were injected into A. stephensi embryos
using the Eppendorf Transjector 5246 and Quartz needles
according to established protocols [47,49]. To generate Cp-Rel2-
GFP transgenic mosquitoes, 1528 A. stephensi eggs were injected
and the 244 hatched larval survivors were screened for transient
expression of the GFP marker (green eyes). Approximately 38%
showed transient expression of GFP, and all 208 survived pupae
were sexed first (123 females and 85 males) and then organized
into about 20 families (12 female and 8 male families). These
different groups of mosquitoes were outcrossed to wild-type
mosquitoes independently with about 9 survived G0 female
mosquitoes crossed with 3 wt male mosquitoes (3:1), while 9
survived G0 male mosquitoes were crossed with 45 wt female
mosquitoes (1:5). The F1 progeny was examined for green
fluorescent glowing eyes at both larval and adult stages. Eleven
eGFP-expressing mosquitoes from 20 different groups were
collected and outcrossed to the wt mosquitoes (in each generation
10 female transgenics were outcrossed with about 5 wt non-
transgenic parental male mosquitoes) for consecutive 4 generations
which finally gave rise to 11 independent trangenic lines (named
from Cp1 to Cp11). For the Vg-Rel2-DsRed transgenic line,
approximately 1500 embryos were injected, and the 210 hatched
larval survivors were screened for transient expression of the
DsRed marker (red eyes). Similarly, these survived mosquitoes
were divided into about 15 families which were outcrossed with wt
mosquitoes in the individual groups which finally gave rise of three
independent Vg-Rel2-DsRed lines (named Vg1, Vg2 and Vg3).
Among all these lines, Cp11 and Vg1 were selected for further
studies. After five generations of outcrossing, homozygous Cp11
and Vg1 lines were generated for further characterization. After 5
generations of outcrossing, heterozygous Cp11 or Vg1 mosquitoes
were subsequently kept interbreeding for about 5 generations to
generate homozygous lines of Cp or Vg for further characteriza-
tion, in addition to producing a hybrid line. In each generation,
about 20 female transgenic Cp or Vg mosquitoes which showed
the strongest fluorescence in eyes (either green for Cp or red for
Vg) were collected and interbred with about 7 male Cp or Vg with
similar fluorescent intensities in the eyes. The offspring were
collected and kept interbreeding in the same manner for another 4
generations until the homozygosity was determined, when
outcrossing of homozygous female mosquitoes with wt male
mosquitoes produced not a single offspring mosquito with wt
phenotype. Homozygous Cp or Vg mosquitoes were subsequently
interbreeding and used for Plasmodium infection assays. Female
homozygote Cp11 was crossed with male Vg1 to generate a third
hybrid transgenic line (Hyb, with both green and red eyes when
viewed with appropriate fluorescent filters). After screening of
hybrid mosquitoes for more than five generations (each generation
of transgenic larvae were screened for both green and red eyes), we
were unable to obtain homozygous Hyb mosquitoes, probably due
to an unknown mechanism which needs further characterization.
Finally in each generation there were always about 25% larvae
with only one color of fluorescence in the eyes, and the hybrid line
we used in this study is a mixture of homozygotes and
heterozygotes which is thereafter referred as ‘‘heterozygote’’.
Further work will be required to provide potential explanations for
this observation. To assure that the hybrid line harbors both Cp-
Rel2 and Vg-Rel2, hybrid mosquitoes were screened every
generation for the assays. The homozygous Cp11 and Vg1
mosquitoes, heterozygous hybrid mosquitoes (Cp11, Vg1, and
Hyb) were used for all the assays performed after the initial P.
falciparum infection screen and were referred to as the Cp-, Vg- and
Hyb- lines. The wt control (parental) colony mosquitoes were
reared in parallel to the transgenic mosquitoes for all the infection
assays.
Genomic DNA extraction and Southern hybridization
Genomic DNA (gDNA) was extracted from wild type, Cp1 to
Cp11, Vg1 to Vg3 strains by using Qiagen DNeasy Tissue kit.
About 0.1 mgo fgDNA was used for PCR to confirm the insertion
of transgene (Rel2), GFP or DsRed in the transgenic mosquitoes
by using the primers (Rel2-veri, GFP-veri, DsRed-veri) listed in
Table S1. Southern hybridization analysis was done as described
in [13] with some modifications. Briefly, for each mosquito strain
tested, about 15 mg gDNA was digested by using EcoRI, HindIII
(New England Biolabs). After precipitation of the digested
products, the DNA pellets were resuspended in 20 mlo fT E
buffer, and loaded on a 0.8% agarose gel which ran about 4
hours (or overnight) to separate the DNA fragments. After
alkaline transfer of DNA to a positive charged nylon membrane
(Roche), the membrane was hybridized with the DNA probes of
Rel2, right piggyBac arm for EcoRI-restricted DNA, and GFP,
DsRed region for HindIII-digested DNA. The probe labeling and
hybridization were done by using DIG High Prime DNA
Labeling and Detection Kit (Roche). Detailed probe sequence
regions are presented in Figure S1A.
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RNA intereference (RNAi)-mediated gene silencing
RNA was extracted and quantified (in triplicate samples) in
different tissues (whole mosquito, gut, and fat-body) using RNeasy
kit (Qiagen), and cDNA was prepared using oligo(dT) primer
according to standard methodology using Invitrogen Superscript
III reverse transcriptase. The quantitative real-time PCR (qRT-
PCR) and RNAi gene-silencing assays were done according to
[10] with primers from Table S2, and the ribosomal protein S7
gene was used for normalization of the cDNA templates. The -fold
change in the gene expression and the gene silencing efficiency
(from RNAi assays) were calculated according to the standard
E
DDCt method [50] when both primer efficiencies between GOI
(gene of interest) and S7 gene are equal. The primer efficiencies
were determined as described in [50].
Several A. stephensi immune genes (TEP1, LRRD7, APL1, and
PGRP-LC) were screened for anti-Plasmodium defense activity and
potential immuno-regulatory function using RNA interference
(RNAi) in the wild-type, Cp-, Vg-, and Hyb- lines. For these
assays, the gene mRNA was selectively depleted from the adult
female mosquitoes using established RNAi methodology [22]. The
dsRNA injection assay of different genes was repeated at least three
times with at least 80 mosquitoes in each experiment; the GFP
dsRNA-injected mosquitoes served as controls. The RNAi gene
silencing efficiencies were determined for all WT, Cp11, Vg1, and
hybrid lines at 3 d post dsRNA injection for all 4 genes tested
compared to dsGFP injected control mosquitoes. Considering that
the transgene Rel2 and the effector genes are strongly induced post
blood meal in the transgenic mosquitoes, therefore we also
checked the gene silencing efficiencies at 24 h post blood feeding
(pbf) for TEP1, LRRD7, and PGRP-LC genes (Table S2). The
primers used for dsRNA synthesis and silencing verification, along
with the gene silencing efficiencies, are presented in Table S2.
P. falciparum and P. berghei infection assays
To determine the anti-Plasmodium activities, the transgenic and
wild-type mosquitoes were fed on either NF54 or 3D7 (GFP) P.
falciparum gametocyte cultures (provided by the Johns Hopkins
Malaria Institute Core Facility, Sanaria, and Dr. Sinden) [51]
through artificial membranes at 37uCo ro naP. berghei ANKA
(GFP)-infected Swiss Webster mouse (at 19uC) [10,52]. The NF54
P. falciparum clone (Sanaria) was used throughout the study except
for Figure 1C where the 3D7 (GFP) clone was used to generate a
representative view of comparing P. falciparum oocysts infection
intensities in different transgenic and wt mosquitoes. The adult
mosquitoes were starved for 8–10 h prior to feeding to ensure
engorgement. To determine oocyst numbers, unfed mosquitoes
were removed after 24 h, and the rest were incubated for a further
7 days at 27uC or 13 days at 19uC for P. falciparum and P. berghei,
respectively. Midguts were dissected out in PBS, stained with 0.2%
mercurochrome, and examined using a light-contrast microscope
(Olympus). At least three biological replicas were performed for
each experiment, and oocyst numbers from equal numbers of
midguts from different replicates were pooled for producing the
dot-plot through GraphPad Prism5 software.
Ookinete counting in the mosquito guts and lumen was done
according to established methodology [37,38], with minor
modifications. The guts, including the entire bloodmeal contents,
were placed in Corning 96-well plates with 40 ml of sterile PBS and
individually homogenized by repeated pipetting; 10 ml of this
homogenate was then spotted onto Teflon-printed microwell glass
slides (VWR International) previously coated with 3-aminopropyl-
triethoxysilane (APES) according to the supplier’s instructions
(Sigma). The sample slides were then air-dried and fixed with
methanol, then stained with Giemsa stain for 45 min and analyzed
under a Nikon E800 microscope. The total number of ookinetes in
each spotted sample was counted, and average values for the
densities of the ookinetes were calculated from at least two
biological replicates. These average values were then multiplied by
the dilution factor of the sample (1 in 4) to give an estimate of the
total number of each malarial parasite stage that was present
within the entire blood meal.
A method described in [38] was used to determine the
sporozoite loads in the salivary glands of the infected mosquitoes,
salivary glands were dissected, and individual glands were placed
in Eppendorf tubes with 120 ml of PBS, then homogenized (on
ice). The homogenate was centrifuged at 8,000 rpm for 10 min,
followed by the removal of approximately 90 ml of supernatant.
The sporozoites were resuspended in the final 30 ml of PBS, and
10 ml of this suspension was placed in a Nuebauer counting
chamber and counted after 10 min using a Leica phase-contrast
microscope at 400x magnification.
The dot plots of the ookinete, oocyst, and sporozoite numbers in
each gut lumen, gut epithelium, and salivary gland, respectively,
for each treatment were generated using GraphPad Prism5
software, along with the median value indicated. For the statistical
analysis, we first tested statistical differences between different
replicates within the same treatment as described in [5], then
pooled the replicates from the equal number of samples
(randomized before pooling) for the dot plots when no differences
between replicates were detected. Since the Plasmodium infection
prevalence did not show great variations between the wt and
transgenic mosquitoes when at the higher infection levels, we
included midguts with zero oocyst in our analyses as described in
[4,37,53]. P-values were calculated through non-parametric
Mann-Whitney test or Kruskal-Wallis (KW) ANOVA on ranks
and used to determine the significance of differential infection
levels as described in [5,37]. To gain a more detailed picture of
prevalence and infection intensity, we separated these two
attributes into two data sets for the statistical analysis as presented
in Table S3, where prevalence of oocysts was analyzed for each
replicate independently and were then pooled and analyzed.
Significant differences of prevalence were determined through a
Wald Chi-square test as described in [5,32]. Median parasites
numbers and range of all mosquitoes that were infected are also
presented in Table S3.
Bacterial challenge survival assay and characterization of
proliferated midgut microbial flora
Isolation and colony-forming unit (CFU) enumeration of
endogenous gut bacteria from WT, Cp-, Vg-, and Hyb- female
mosquitoes were performed as described previously, with modi-
fications [37,54]. Age-matched mosquitoes were provided with a
blood meal, and engorged mosquitoes were separated and kept
under standard insectary conditions for the remainder of the
experiment. On the day of the blood-feed, unfed mosquitoes from
each cohort were selected for analysis, while blood-fed mosquitoes
were used for all analyses post-blood meal (PBM). Each mosquito
was surface-sterilized by washing twice with 70% ethanol and
rinsing in sterile PBS; to determine the efficacy of sterilization,
mosquitoes were placed on LB agar prior to dissection. The gut
was dissected with sterile forceps and placed in sterile PBS. Ten-
fold serially diluted midgut homogenates were plated on LB agar
and incubated at ambient temperature for 4 days. Each
experiment was performed using an individual gut, and results
are representative of eight individual experiments.
Survival assays conducted following bacterial challenges of Rel2
transgenic mosquitoes were conducted as an adaptation of an
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were fed on anesthetized mice and challenged with bacteria at 3–
6 h PBM. An overnight LB culture of bacteria were further
washed and re-suspended in PBS; 69 nl of the bacterial suspension
was injected into the mosquito’s thorax with a nano-injector
(Nanoject, Drummond) at 350,000 CFU (for E. coli) and
210,000 CFU (for S. aureus) per mosquito. For negative controls,
69 nl of PBS was injected into WT, Vg, or Cp mosquitoes. Dead
mosquitoes were counted and removed from cages daily over a 4 d
period after challenge with bacteria. Forty blood-fed females were
used for each group of injected mosquitoes, and at least three
replicates were performed for all experiments. The significance of
transgene Rel2 expression for the mosquitoes’ susceptibility to
bacterial infection was determined using Kaplan-Meier survival
analysis with log-rank test used for significance evaluation with
GraphPad Prism5 software as described in [54] (Kaplan-Meier
survival curves are presented in Figure S5).
Longevity, fecundity, and egg hatchability assays
Before these experiments were carried out, the three transgenic
lines were outcrossed with non-transgenic wild-type mosquitoes for
at least three generations to ensure a genetic background similar to
that of the wt control mosquitoes, and heterozygous Cp, Vg, and
hybrid lines were used for the assays. Crosses between heterozy-
gous transgenic (Cp and Vg) and wt parental non-transgenic
mosquitoes produced a 50/50 ratio of transgenic to wt siblings.
Meanwhile, the non-transgenic wild type colony mosquitoes used
for outcrossing were maintained under exactly the same conditions
as the transgenic mosquitoes. These offspring were then used for
the following assays: For longevity assays with mosquitoes
maintained on sucrose solution only, approximately 50 to 80 4-
d-old adult female wild-type and transgenic mosquitoes (Cp, Vg,
and Hyb) were kept in a wax-lined cardboard cup at 27uC with
70% humidity and maintained on a sterile 10% sucrose solution.
The mosquitoes’ survival rate was also monitored by providing a
single naı ¨ve human blood meal to 5-d-old mosquitoes that were
then maintained on 10% sucrose solution, or by providing three
naı ¨ve human blood meals to 5-d-old mosquitoes (at day 0, 4, 8)
followed by maintenance on a 10% sucrose solution until day 30;
after each feeding, the unfed mosquitoes were identified, recorded,
and removed. At day 0 the 100% survival refers to those
mosquitoes fed for the first time, for the second and the third
blood-feeding, the mosquitoes which did not feed were removed
and censored in the survival analysis. Blood-feeding propensity of
the transgenic lines did not show difference from that of wt
mosquitoes, therefore not shown here. Alternatively, 5-d-old
mosquitoes were provided with a Pf-infected blood meal (0.3%
gametocytemia) and then maintained on a 10% sucrose solution,
and the infection level was then confirmed by counting the oocysts
at 8 days post-infection from 10 mosquitoes for each treatment.
Three independent experiments were performed, and all cohorts
were monitored daily for survival; the dead mosquitoes were
removed each day. Monitoring continued until all mosquitoes had
perished. The survival percentage represents the mean survival
percentage for all three biological replicates of 50 to 80 mosquitoes
each (the exact numbers of mosquitoes were recorded in Table S4)
as described in [4]. Statistical significance was determined by
Kaplan-Meier survival analysis with GraphPad Prism5 software,
and p-values were determined by Wilcoxon test as described in
[32]. For the fecundity assay, approximately 50 4-d-old adult
female wt and transgenic mosquitoes (Cp, Vg, and Hyb) were
allowed to feed on human blood through an artificial membrane
feeder for 30 min. The fed mosquitoes were transferred to
individual wax-lined cardboard cups (one mosquito per cup)
outfitted with cotton soaked in 10% sucrose solution and an
oviposition cup filled with water and lined with the filter paper.
Individual chambers were incubated under normal rearing
conditions. Eggs oviposited on filter paper were counted after 2
d using light microscopy. Female mosquitoes that did not produce
eggs on day 2 were maintained and re-examined on day 3. After
each count, eggs were submerged in a standard larval pan for
rearing according to standard methods. First instar larvae were
counted and removed from the larval pan daily to determine the
larval hatch rate. The fecundity and larval hatch-rate assays were
performed for three consecutive generations (three biological
replicates), and the number of eggs laid by each female and their
hatch rate were pooled to calculate the median value. Statistical
significance was determined using the Mann-Whitney test.
Supporting Information
Figure S1 Generation of Rel2 transgenic lines in A.
stephensi. (A) Schematic representation of the pBac-EGF-
P[AgCp-Rel2-TryT] and pBac-DsRed[AgVg-Rel2-TryT] transfor-
mation plasmids used for the germline transformation of A.
stephensi. The restriction sites used for DNA digestion for Southern
hybridization are indicated; the thick horizontal black lines
indicate the probes (GFP, DsRed, piggybac Right arm) regions.
Double-headed arrows indicate the sizes of the inserts of AgCp-Rel2
and AgVg-Rel2 for making the constructs. The sizes of each region
of the corresponding constructs are indicated by the numbers
above the schematic map. (B) Bright-field and fluorescent images
of larvae and adults of the Cp, Vg, and Hyb transgenic lines. The
control wild-type (WT) is also shown. (C) PCR confirmation and
Southern blot analysis of transgene integration. In each row,
column 1 shows the transgenic line DNA, column 2 the non-
transgenic control WT DNA, and column 3 the plasmid DNA
used in germ-line transformation. The top row is the PCR
amplification of the fluorescent marker (GFP for Cp, and DsRed
for Vg), and the middle row is the PCR amplification of the Rel2
transgene. The lower row is a Southern blot analysis of the Rel2
transgene on EcoRI-digested genomic DNA (gDNA) of the
transgenic Cp11 and Vg1 lines, WT, and control plasmid. (D)
Southern blot analysis of the genomic DNA isolated from the
representative Cp and Vg transgenic strains and the wild-type
control strain. HindIII and EcoRI were used for the gDNA
digestion, probes from PCR products of GFP, DsRed, and piggyBac
right arm were used for the Southern hybridization. WT: wild-
type control parental strain; Cp: Cp lines; Vg: Vg lines.
(TIF)
Figure S2 P. falciparum (NF54) oocyst loads in hetero-
zygous transgenic Cp and Vg mosquitoes. Cp (A) and Vg
(B) heterozygous mosquitoes were fed on human blood with a
standard 0.3% gametocytemia and the midguts were dissected at
8 dpi for oocysts counts. Each assay was performed with at least
two biological replicates, and the oocyst loads from equal number
of samples (midguts) from the different replicates were pooled for
the dot-plot. Each circle represents the number of oocysts in an
individual gut, and the horizontal lines (red or green) indicate the
medians. P-values were calculated using a Mann-Whitney test by
comparing to wild-type (WT) control mosquitoes.
(TIF)
Figure S3 P. falciparum sporozoite loads in the salivary
glands of wild type and hybrid transgenic mosquitoes
that were provided a second blood meal. P. falciparum
sporozoite loads in the salivary glands (SG) of the wild type (WT)
and hybrid (Hyb) transgenic mosquito lines which had either been
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naı ¨ve blood meal at 8 days after the initial Pf-infected blood meal
(Re-fed). At least two biological replicates were included in each
assay and the sporozoite numbers from equal numbers of salivary
glands of different replicates were pooled for the dot-plot analysis.
Each circle represents the number of sporozoites in the salivary
glands of an individual mosquito, the horizontal lines (red) indicate
the medians and p-values were calculated using a Mann-Whitney
test.
(TIF)
Figure S4 Transgenic mosquito anti-P. berghei activity.
P. berghei oocyst infection intensities of the wild type (WT), Cp, Vg,
and hybrid transgenic mosquito lines at 14 dpi. At least three
biological replicates were included in each assay and the oocyst
loads from equal number of mosquito midguts from the different
replicates were pooled for the dot-plot analysis. Each circle
represents the number of oocysts in an individual mosquito, and
the horizontal lines (red) indicate the medians (including zeros) and
p-values were calculated using a Mann-Whitney as indicated here
and Kruskal-Wallis (KW) test (in Table S3). Detailed statistical
information of N, range, medians with or without zeros,
prevalence and p-values from either Mann-Whitney or KW tests
are presented in Table S3.
(TIF)
Figure S5 Kaplan-Meier survivorship curve comparing
transgenic (Cp, Vg) and non-transgenic (WT) mosqui-
toes after systematic bacterial infection. Cp, Vg, and WT
mosquitoes were reared under identical conditions after challenge
with either Gram-negative (E. coli: 350,000 CFU; Ec) or Gram-
positive (S. aureus: 210,000 CFU; Sa) bacteria at 4 dpi. Three
biological replicates were shown here. Kaplan-Meier survival
analysis was used together with log-rank test to determine the p-
values, and p,0.05 indicates significance (Figure 3B).
(TIF)
Table S1 Primers used for generation of constructs for
embryo microinjections and the verification of trans-
gene integration. AgCp and AgVg denote A. gambiae carboxy-
peptidase A and vitellogenin 1 promoters respectively. Veri:
verification primers. Letters in bold, Italic,o runderlined in the
‘‘Primer sequence’’ indicate the restriction sites or the special
sequences which were used for the cloning. ‘‘RE sites, Notes’’
indicates the restriction enzyme used with the same font format as
in ‘‘Primer sequence’’.
(DOC)
Table S2 Primers used for gene expression analysis,
production of PCR amplicons for dsRNA synthesis, and
qRT-PCR validation of RNAi-mediated gene silencing
and the efficiencies of gene silencing. Underlined letters
indicate the T7 promoter sequence, and the same pair of the
forward (RNAiF) and the reverse primers (RNAiR) was used for
both dsRNA synthesis and qRT-PCR expression analysis of the
corresponding genes. For gene silencing validation, the different
veriF (verification forward primer) and RNAiR (dsRNA synthesis
reverse primer) were used. KD% (6 SE) denotes the efficiency of
gene knock-down (KD) % on average with standard error. The
silencing efficiency was determined at 3 d post dsRNA injection,
before P. falciparum infected blood feeding, or 24 hours post blood-
feeding (24 h pbf).
(DOC)
Table S3 Statistical analyses of ooycsts, ookinetes, or
sporozoites in WT, Cp, Vg, and Hyb mosquito midguts,
midgut lumens, or salivary glands, respectively; and the
effect of gene silencing on P. falciparum infection (oocyst
loads) in WT, Cp, Vg, and Hyb mosquitoes. n: total
midguts, midgut lumens or salivary glands numbers; range: range
of oocysts, ookinetes, or sporozoites numbers; prevalence: % of
mosquitoes with at least one parasite; Chi-square test p-value: for
determine the significance of prevalence; median (with zeros):
median oocysts, ookinetes, or sporozoites from 3 biological
replicates when zeros were included; median (without zeros):
median from 3 replicates when zeros were excluded; % decreased
oocysts #: the % decrease in the oocyst loads; % inhibition: the %
decrease in the ookinete or sporozoite loads; % increased oocysts
#: the % increase in the oocyst loads. The p-values from Kruskal-
Wallis and Mann-Whitney test are presented where *: p,0.05 or
p,0.01; **: p,0.001; ***: p,0.0001; ns: no significance.
(DOC)
Table S4 Survival analysis of transgenic and wt control
mosquitoes after sugar-feeding, blood-feeding, or P.
falciparum infected blood-feeding.
(DOC)
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